Minerva Neurosciences, Inc.·4

Oct 5, 4:34 PM ET

Luthringer Remy 4

4 · Minerva Neurosciences, Inc. · Filed Oct 5, 2023

Insider Transaction Report

Form 4
Period: 2023-10-04
Luthringer Remy
EVP and Head of R&D
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-10-04+100,450100,450 total
    Exercise: $6.41Exp: 2033-10-03Common Stock (100,450 underlying)
Footnotes (1)
  • [F1]The option vests 25% on October 4, 2024 and then in equal quarterly installments over 3 years thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION